Anbio Biotechnology Class A Ordinary Shares Cash Flow Quality Index
Anbio Biotechnology Class A Ordinary Shares cash flow quality index. Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Cash Flow Quality Index of 0.17x as of June 2024. Operating cash flow of $647.54K is below net income of $3.89 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Anbio Biotechnology Class A Ordinary Sha to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Cash flow quality index of Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025. Historical Cash Flow Quality Index for Anbio Biotechnology Class A Ordinary Shares across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Anbio Biotechnology Class A Ordinary Sha to assess how comfortably operating cash covers total debt obligations.
Anbio Biotechnology Class A Ordinary Shares Cash Flow Quality Index by Year (2021–2025)
Anbio Biotechnology Class A Ordinary Shares cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for Anbio Biotechnology Class A Ordinary Shares. For the full cash flow conversion analysis, see how efficiently does Anbio Biotechnology Class A Ordinary Sha generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.05x | $-6.74 Million | $6.40 Million | ▼ -220.0% |
| 2024 | 0.88x | $2.08 Million | $2.37 Million | ▲ +119.9% |
| 2023 | 0.40x | $898.37K | $2.25 Million | ▼ -10.3% |
| 2022 | 0.44x | $4.45 Million | $10.01 Million | ▼ -73.0% |
| 2021 | 1.65x | $4.18 Million | $2.54 Million | — |